3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Melanoma
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Syndrome
1
Spondylitis, Ankylosing
1
Skin Carcinoma
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplasm Metastasis
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Lung Neoplasms
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Fatigue
1
Endometrial Neoplasms
1
Dyspnea
1
Disease
1
Crohn Disease
1
Cough
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Biopsy
7
pembrolizumab
6
Doxorubicin
6
Cyclophosphamide
6
X-Rays
4
Radiation
4
Phantoms, Imaging
4
Radiotherapy
3
Nuclear Medicine Department, Hospital
3
Irinotecan
3
Ifosfamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pazopanib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
ensartinib
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Educational Status
×
30 days
×
Clear all
No trials found.